Variants egln2 and use of same in the prevention or treatment of thromboembolic diseases and coronary heart disease

摘要

Variants egln2 and use of same in the prevention or treatment of thromboembolic diseases and coronary heart disease.The present invention relates to variants of human egln2 with a serine or a leucine at position 58 of the sequence of amino acid and their use in the prevention or treatment of thromboembolic diseases or coronary heart disease, especially stroke, neurological disability Prolonged ischemic reversible (prind), transient ischemic attack (TIA).Myocardial infarction and / or premature myocardial infarction.